Jun 2026 (Q2 FY26) — Jul 23, 2026
Community Health Systems Q2 FY26 — Adjusted Guidance Amid Payer Mix and Elective Procedure Headwinds
Read the full callCommunity Health Systems earnings: last reported Thu, 23 Jul 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 2,825 | −9.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 13.8 | −2.6 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 70.0 | −75.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
1Y: $3.23 on 22 Oct 2025 → $2.92. High $4.41 (27 Oct 2025), low $2.49 (23 Apr 2026).
Overview
Call summaries
Community Health Systems Q2 FY26 — Adjusted Guidance Amid Payer Mix and Elective Procedure Headwinds
Read the full callEvery analysed call
Financials
Net profit, year on year: −75% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 3,090 | 3,264 | 3,159 | 3,133 | 3,087 | 3,106 | 2,965 | 2,825 |
| Expenses | 3,295 | 2,986 | 2,875 | 2,621 | 2,844 | 2,657 | 2,684 | 2,436 |
| Operating profit | -205 | 278 | 284 | 512 | 243 | 449 | 281 | 389 |
| Operating margin | −6.6% | 8.5% | 9.0% | 16.3% | 7.9% | 14.5% | 9.5% | 13.8% |
| Profit before tax | -419 | 64 | 67 | 438 | -2 | 221 | 64 | 180 |
| Tax rate | 15.3% | 142.2% | 62.7% | 26.9% | 8650.0% | 27.6% | 139.1% | 42.2% |
| Net profit | -391 | -71 | -13 | 282 | 130 | 110 | -58 | 70 |
| EPS ($ per share) | -2.95 | — | -0.10 | 2.11 | 0.97 | — | -0.43 | 0.51 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | -3,543 | -4,218 | -3,707 | -3,477 | -3,431 | -3,564 | -4,080 | -3,571 |
| Total liabilities | 16,818 | 17,248 | 17,060 | 16,027 | 15,403 | 15,279 | 15,371 | 14,041 |
| Fixed assets | 6,139 | 5,608 | 5,322 | 5,553 | 5,365 | 5,207 | 4,776 | 4,503 |
| Total assets | 15,859 | 15,609 | 16,006 | 15,217 | 14,669 | 14,455 | 14,054 | 13,204 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 274 | 385 | 2,178 | -131 | 300 | 210 | 480 | 543 |
| Cash from investing | -245 | -2 | 177 | -524 | -259 | -26 | -275 | 847 |
| Cash from financing | -396 | -363 | -895 | -514 | -430 | -264 | -206 | -1,167 |
| Net cash flow | -367 | 20 | 1,460 | -1,169 | -389 | -80 | -1 | 223 |
| Capital expenditure | -527 | -438 | -440 | -469 | -415 | -467 | -360 | -335 |
| Free cash flow | -253 | -53 | 1,738 | -600 | -115 | -257 | 120 | 208 |
40 filings between Dec 31, 2025 and Aug 25, 2026.
Purchases
None
No insider bought shares.
Sales
$118.4K
1 sale by 1 insider
Also filed: 1 gift.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| JENNINGS WILLIAM NORRIS | — | $118.4K | Aug 25, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 25, 2026 | JENNINGS WILLIAM NORRIS Director | Sale | 40,000 | $118.4K |
| Jun 30, 2026 | Krishnan K Ranga Director | Option exercise | 13,930 | $0 |
| Jun 1, 2026 | Rice David V. EVP-Clinical Operations & CMO | Award | 30,000 | $0 |
| Apr 22, 2026 | Krishnan K Ranga Director | Option exercise | 46,950 | $0 |
| Mar 2, 2026 | SMITH WAYNE T Director | Gift | 19,400 | $0 |
| Mar 1, 2026 | DINKINS MICHAEL Director | Option exercise | 20,906 | $0 |
| Mar 1, 2026 | Ely James S. III Director | Option exercise | 9,756 | $0 |
| Mar 1, 2026 | Ely James S. III Director | Option exercise | 20,906 | $0 |
| Mar 1, 2026 | Ely James S. III Director | Option exercise | 19,933 | $0 |
| Mar 1, 2026 | FRY JOHN A Director | Option exercise | 9,756 | $0 |
| Mar 1, 2026 | FRY JOHN A Director | Option exercise | 20,906 | $0 |
| Mar 1, 2026 | FRY JOHN A Director | Option exercise | 19,933 | $0 |
| Mar 1, 2026 | Hirsch Elizabeth T Director | Option exercise | 9,756 | $0 |
| Mar 1, 2026 | Hirsch Elizabeth T Director | Option exercise | 20,906 | $0 |
| Mar 1, 2026 | Hirsch Elizabeth T Director | Option exercise | 19,933 | $0 |
| Mar 1, 2026 | Williams Hubert James Director | Option exercise | 9,756 | $0 |
| Mar 1, 2026 | Williams Hubert James Director | Option exercise | 20,906 | $0 |
| Mar 1, 2026 | Williams Hubert James Director | Option exercise | 19,933 | $0 |
| Mar 1, 2026 | HAMMONS KEVIN J CEO | Option exercise | 156,240 | $0 |
| Mar 1, 2026 | HAMMONS KEVIN J CEO | Award | 200,000 | $0 |
| Mar 1, 2026 | HAMMONS KEVIN J CEO | Tax withheld | 96,896 | $335.3K |
| Mar 1, 2026 | Johnson Jason K EVP & CFO | Option exercise | 30,000 | $0 |
| Mar 1, 2026 | Johnson Jason K EVP & CFO | Award | 90,000 | $0 |
| Mar 1, 2026 | Johnson Jason K EVP & CFO | Tax withheld | 23,610 | $81.7K |
| Mar 1, 2026 | Pitt Justin D Pres,Chief Legal&Admin Officer | Option exercise | 30,000 | $0 |
| Mar 1, 2026 | Pitt Justin D Pres,Chief Legal&Admin Officer | Award | 40,000 | $0 |
| Mar 1, 2026 | Pitt Justin D Pres,Chief Legal&Admin Officer | Tax withheld | 24,922 | $86.2K |
| Mar 1, 2026 | Posey Phillip A. SVP & CAO | Award | 25,000 | $0 |
| Mar 1, 2026 | Brooks Susan W Director | Option exercise | 19,933 | $0 |
| Mar 1, 2026 | STOCKTON KEVIN A EVP, Operations & Development | Option exercise | 50,000 | $0 |
| Mar 1, 2026 | STOCKTON KEVIN A EVP, Operations & Development | Award | 30,000 | $0 |
| Mar 1, 2026 | STOCKTON KEVIN A EVP, Operations & Development | Tax withheld | 35,573 | $123.1K |
| Mar 1, 2026 | Posey Phillip A. SVP & CAO | Tax withheld | 1,188 | $4.1K |
| Mar 1, 2026 | CLERICO JOHN A Director | Option exercise | 9,756 | $0 |
| Mar 1, 2026 | CLERICO JOHN A Director | Option exercise | 20,906 | $0 |
| Mar 1, 2026 | CLERICO JOHN A Director | Option exercise | 19,933 | $0 |
| Mar 1, 2026 | DINKINS MICHAEL Director | Option exercise | 9,756 | $0 |
| Mar 1, 2026 | Brooks Susan W Director | Option exercise | 9,756 | $0 |
| Mar 1, 2026 | Brooks Susan W Director | Option exercise | 20,906 | $0 |
| Dec 31, 2025 | Ely James S. III Director | Option exercise | 2,882 | $0 |
| Jun 1, 2025 | Brooks Susan W Director | Option exercise | 5,894 | $0 |
| Mar 1, 2025 | MEDLEY MARK B Regional President | Award | 25,000 | $0 |
| Mar 1, 2025 | MEDLEY MARK B Regional President | Tax withheld | 15,682 | $47.2K |
| Mar 1, 2025 | Hingtgen Tim CEO | Option exercise | 33,600 | $0 |
| Mar 1, 2025 | Hingtgen Tim CEO | Award | 200,000 | $0 |
| Mar 1, 2025 | Hingtgen Tim CEO | Tax withheld | 78,807 | $237.2K |
| Mar 1, 2025 | HAMMONS KEVIN J President and CFO | Tax withheld | 43,365 | $130.5K |
| Mar 1, 2025 | Brooks Susan W Director | Option exercise | 9,756 | $0 |
| Mar 1, 2025 | Brooks Susan W Director | Option exercise | 20,906 | $0 |
| Mar 1, 2025 | CLERICO JOHN A Director | Option exercise | 5,894 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow COMMUNITY HEALTH SYSTEMS INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading